Business Wire

Pampers and UNICEF Celebrate a Decade Together Helping to Save Millions of Mother’s and Babies’ Lives

Del

An estimated 500,000 newborn lives have been saved and 100 million women and their newborns protected from the deadly disease, maternal and newborn tetanus, thanks to a ten-year long partnership between Pampers® and UNICEF that helped achieve this milestone.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150928006757/en/

New York, 28th September 2015. Pampers and UNICEF celebrate a decade together helping to save 100 mi ...

New York, 28th September 2015. Pampers and UNICEF celebrate a decade together helping to save 100 million women and their babies. Representatives reflected on the successes of the 10 year initiative at the US Fund for UNICEF, including Yoka Brandt, UNICEF Deputy Executive Director, Celebrity Mum & Pampers UNICEF Ambassador Emma Bunton, Gerard Bocquenet, Director of Private Fundraising and Partnerships, UNICEF, Sirma Umur, VP of Baby Care, P&G and Dr. Holly Phillips, CBS News Medical Contributor and event moderator. (Photo: Business Wire)

The partners marked the tenth anniversary of their work today by celebrating the contributions of their joint effort that has helped in the elimination of maternal and newborn tetanus in 17 countries, with the success of the ‘1 Pack = 1 Vaccine’ initiative.

Long-standing spokesperson for the 1 Pack = 1 Vaccine campaign, Emma Bunton, united with Pampers & UNICEF during a global summit in New York to celebrate the progress for mothers and babies as a result of the partnership. At the event, Emma reflected on the decade-long initiative and invited everyone to mark the 10th anniversary by resolving to eliminate maternal and newborn tetanus entirely.

“Working with the people who have been instrumental in the success of this partnership, and meeting some of the mothers and babies who have enjoyed better, healthier lives as a result of the initiative has been an unforgettable experience”, said Emma Bunton.

The 1 Pack = 1 Vaccine campaign has combined two components that are essential to defeating a disease like maternal and newborn tetanus: Raising funds, and raising profile.

“The partnership between Pampers and UNICEF has resulted in much greater awareness of maternal and newborn tetanus.” said Yoka Brandt, UNICEF Deputy Executive Director. “It will take even more commitment and investment, but we can and must accelerate elimination efforts in the remaining 21 countries where the key challenge remains universal access to life saving interventions, including maternal and newborn tetanus vaccines.”

And although much has already been achieved, there is more work to be done, as maternal and newborn tetanus still threatens the lives of 71 million women and their newborns.

Sirma Umur, Pampers VP babycare E-IMEA says “We continue to partner with UNICEF to help protect the world’s babies against this deadly disease and invite everyone to join us in our 10th anniversary wish to eliminate maternal and newborn tetanus entirely.”

Tetanus is caused by bacteria that live in soil. Newborns are often infected as a result of unhygienic birth practices, such as cutting the umbilical cord with un-sterile instruments or handling it with dirty hands. Once contracted, there is no real cure. Nearly all babies who contract tetanus die, unless they receive treatment.

The true extent of the newborn tetanus death toll is not fully known, since the population at the highest risk of contracting the disease tends to live in rural areas with little or no access to health care services or education.

Newborn tetanus can be prevented through a simple vaccination given to pregnant women and women of a child-bearing age, to protect both the woman and her unborn child during this vulnerable period. Following administration of the tetanus vaccine to a pregnant mother, the antibodies pass across the placenta to her foetus.

World Health Organisation (WHO) and UNICEF recommend three appropriately spaced doses of the tetanus vaccine in order to ensure long-lasting immunity. After two doses, a woman who is vaccinated before she gives birth will be protected against the disease for three years. After three doses she will be protected for five years, and in both cases, will share her protection with her baby for the first two months of life

About UNICEF

UNICEF promotes the rights and wellbeing of every child, in everything we do. Together with our partners, we work in 190 countries and territories to translate that commitment into practical action, focusing special effort on reaching the most vulnerable and excluded children, to the benefit of all children, everywhere. . For more information, please visit www.unicef.org .

Pampers® cares for the development of every baby around the world and continuously works in partnerships with NGOs, charity organizations, hospitals and healthcare professionals to help make a difference. Some of the many initiatives which demonstrate Pampers® ongoing commitment to vulnerable and disadvantaged babies around the world include education programmes for mothers and mothers-to-be, training schemes for physicians and nurses, and the donation of equipment for maternity wards and orphanages. Visit for more information: www.Pampers.co.uk/UNICEF

Contact information

For Pampers:
Colleen Cleary, 631-921-5320
colleen.cleary@hkstrategies.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

More than 70 Companies to Showcase Top Tech at CES Unveiled Paris20.10.2017 15:08Pressemelding

The Consumer Technology Association (CTA) today announced that more than 70 exhibitors will showcase their latest innovations at the now sold-out fifth annual CES Unveiled Paris The event will focus on the Internet of Things (IoT), connectivity and smart cities, and draw more than 600 attendees. CES Unveiled Paris will run from 2-7:30 PM on Tuesday, October 24, 2017 at the Palais Brongniart. Regional technology companies, top-tier media outlets, buyers and key industry influencers will come together at CES Unveiled Paris to get a direct look at the latest industry developments. The day kicks off with a CES news conference and CTA market trends presentation. Conference programming is followed by a tabletop exhibition & networking reception. Curated exhibitors will be there to showcase top tech from robotics and audio to smart home and augmented and virtual reality. Notable

Westinghouse Receives Regulatory Approval for Analysis Methodologies20.10.2017 12:15Pressemelding

Westinghouse Electric Company today announced that it has received approval from the U.S. Nuclear Regulatory Commission (NRC) for two new important analysis methodologies that will be used to upgrade Westinghouse- and Combustion Engineering-based nuclear steam supply system (NSSS) safety analyses. The approvals granted are for the new FULL SPECTRUMTM Loss of Coolant Accident (FSLOCATM) methodology and the Performance Analysis and Design Model software code update, PAD5. FSLOCA is capable of improved modeling of the transient response in a pressurized water reactor to the full spectrum of LOCA break sizes that could occur, and PAD5 is the next generation of the Westinghouse fuel rod design performance code. “These codes were developed to work in concert with each other to maximize analytical margin for nuclear utilities,” said Michele DeWitt, senior vice preside

Gilead Announces Multiple Scientific Presentations Demonstrating High Cure Rates in Difficult-to-Cure HCV Patients and Improved Long-Term Bone and Renal Safety of Vemlidy® in HBV Patients Switched from Viread®20.10.2017 12:03Pressemelding

Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from Phase 2 and Phase 3 studies of its approved medicines for chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection, adding to the body of evidence supporting Gilead’s viral hepatitis therapies in diverse patient populations. These and other data from more than 25 abstracts will be presented this week at The Liver Meeting® 2017, which begins today in Washington, D.C. Positive results from studies of Harvoni® (ledipasvir 90mg/sofosbuvir 400mg) in HCV-infected patients with severe renal impairment, Epclusa® (sofosbuvir 400mg/velpatasvir 100mg) in HCV-infected liver transplant recipients and Vosevi® (sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg) in NS5A-inhibitor experienced HCV-infected patients will be presented during poster sessions on October 21 and October 22. In addition, updated results f

SP3H Announces That It Has Obtained a €1.2 Million European Union Grant for Its Intelligent and Clean Vehicle (VIP) Project20.10.2017 10:47Pressemelding

SP3H is proud to announce joining the very select circle of the 10 French winners of the H2020 SME Instrument Phase 2 program since 2014. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171020005325/en/ Last summer VIP received the very prestigious SME instrument phase 2 H2020 label in the "transport & smart cities mobility" category. With an overall budget of € 1.7 million, VIP is subsidized by the European Union at a rate of 70% or €1.2 million. The framework contract was officially signed early October. VIP is the pre-industrialization program for Fuelbox sensors, the world's first miniaturized scanner capable of analyzing the quality of fuels on board vehicles. The heart of the program remains closely linked to the reduction of CO2 and pollutant emissions from vehicle

Kennedy Wilson and Kennedy Wilson Europe Real Estate Plc Complete Merger, Creating $8 Billion Global Real Estate Company20.10.2017 10:00Pressemelding

Global real estate investment company Kennedy-Wilson Holdings, Inc. (NYSE:KW) (“KW”) today announced the completion of its merger with Kennedy Wilson Europe Real Estate Plc (LSE:KWE) (“KWE”). The transaction creates a leading global real estate investment and asset management platform with an $8 billion enterprise value. “This transformative combination with KWE represents an exciting new chapter for our company,” said William J. McMorrow, Chairman and CEO of KW. “We are moving towards a simplified corporate structure that provides more recurring income from stable property cash flows and greater upside potential from value-enhancing initiatives worldwide. We are well positioned for future growth and to continue our track record of generating attractive risk-adjusted returns on our invested capital.” “We are thrilled to combine the financial strength of KW and KWE to continu

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom